Pathophysiological Explorations of Red Blood Cells — GR-Ex

Red Blood Cell Disorder Clinical Trial

Official title:
Pathophysiological Explorations of Red Blood Cells

Status Recruiting

Clinical Trial Summary

GR-Ex is a program labelled by Labex (Laboratory of Excellence) by the French Ministry of Higher Education and Research. This program aims to develop the means to improve knowledge in the physiology and pathologies of erythropoiesis, red blood cells and iron metabolism, and to develop new therapeutic protocols capable of providing added value in terms of innovation.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Red Blood Cell Disorder

Clinical Trial Details

NCT number	NCT03541525
Study type	Observational
Source	Imagine Institute
Contact	Sandra Manceau, PhD
Phone	+33171196435
Email	sandra.manceau@aphp.fr
Status	Recruiting
Phase
Start date	October 16, 2017
Completion date	October 15, 2037

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05754294` - Electric Polarization of Red Blood Cells : A Cohort Study to Assess the Erythrocytes Membrane Integrity Through Charge Conservation, Following Cardiac Surgery.
Recruiting	`NCT06151548` - Effect of Krill Oil Supplementation on Red Blood Cell Physiology Against Changes in Markers of Iron Metabolism.	Phase 4
Not yet recruiting	`NCT05267145` - The Protection of ACD III on Erythrocytes in Intraoperative Blood Salvage During Cardiopulmonary Bypass	N/A
Recruiting	`NCT03214354` - Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor	Phase 2